Outlook Therapeutics Inc OTLK

$0.59 -0.01 (-1.49%)

Valuation

Market cap
145,801,000
Revenue TTM
$1,410,000
Net income TTM
$-62,420,000
PE ratio
0.00
Forward PE
—
Profit margin
-4,426.95%
Debt to equity
-1.75

Trading

Volume
2,309,900
Avg volume
12,018,490
Day's range
$0.57 – $0.60
Shares out
243,448,000
Stochastic %K
65%
Beta
0.66
Analysts
Sell
Price target
$5.03

Price

Company profile

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outl...

Show more

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Industry
Biotechnology
Sector
Healthcare
Phone
609 619 3990
Website
https://outlooktherapeutics.com
Address
111 S. Wood Avenue, Unit #100, Iselin, United States

Latest news

Stocktwits

IniG Oct 12, 8:20 PM
$OTLK "Lytenava (Bevacizumab-vikg) Is FDA-Approved: What It Means for Retina Billing and Anti-VEGF Drug Costs" https://www.ophthalmologybillco.com/resources/weekly-news/lytenava-bevacizumab-biosimilar-retina-billing-2026
1 replies
SayZero Oct 12, 7:52 PM
$OTLK I gave back some profit but time is money too. I will monitor.
0 replies
DidYouReadThis Oct 12, 5:38 PM
$OTLK most likely month for $1 per share or higher:
0 replies
DidYouReadThis Oct 12, 5:36 PM
$OTLK
0 replies
SayZero Oct 12, 5:36 PM
$OTLK I think we may go flat or green at end of day.
0 replies
DidYouReadThis Oct 12, 5:35 PM
$OTLK December 18, 2026 #revenue #prediction closest to:
0 replies
adayxs Oct 12, 5:30 PM
$OTLK Sales is what matters. When they show things will change.
0 replies
TickrTalk0007 Oct 12, 5:20 PM
$OTLK total garbage.....shut down the company
3 replies